Earnings per Pfizer share 2008-2023

Pfizer generated a net income of approximately 2.1 billion U.S. dollars in 2022. The company reported basic net earnings per common share of 0.38 U.S. dollars.

The impact of rising costs on earnings per share

The net income of Pfizer dramatically decreased by around 29 billion U.S. dollars between 2022 and 2023, and this is evident in the company’s net earnings per share, which decreased by over five U.S. dollars. Rising research and development costs can be a contributing factor in the decrease of the net income. In relation to revenues, the pharmaceutical industry is one of the biggest investors in research and development.

Revenues increased due to COVID-19 vaccine

Thanks to record-breaking sales of COVID-19 vaccine Comirnaty, Pfizer generated its highest total revenues in the years 2021 and 2022. In general, the majority of Pfizer’s revenues comes from the manufacture and sale of its products, and revenues from the company’s domestic market of the United States accounts for a share of between 40 and 50 percent. Pfizer sells its pharmaceutical products in more than 125 countries worldwide, with the United States, China, and Japan being its three largest markets.